Endocrine & Diabetes Controversies in Adult Primary Care Practice 2020
Endocrine & Diabetes Controversies in Adult Primary Care Practice is organized by Harvard Medical School (HMS) and will be held from Apr 24 - 26, 2020 at Revere Hotel Boston Common, Boston, Massachusetts, United States of America.
Who Should Attend:
Clinicians seeking a useful and comprehensive update on endocrine diseases and diabetes.
• Family Physicians
The Harvard Medical School designates this live activity for a maximum of 11.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This Live activity, Endocrine & Diabetes Controversies in Adult Primary Care Practice, with a beginning date of 04/24/2020, has been reviewed and is acceptable for up to 10.50 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the criteria of the Massachusetts Board of Registration in Medicine for 2.00 credits of Risk Management Study. Please check your individual state licensing board requirements before claiming these credits.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 10.50 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.
Harvard Medical School is accredited as a provider of continuing education by the Accreditation Council for Continuing Medical Education (ACCME) and this activity is applicable to diabetes. Any diabetes educators who wish to use this activity towards their requirement for CDE renewal of certification can self-report this activity to the NCBDE. If you are chosen for audit, the certificate provided to you after completion of the course evaluation will be sufficient for this audit.
For the purpose of recertification, the American Academy of Nurse Practitioners Certification Board and American Nurses Credentialing Center accept AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME (Accreditation Council for Continuing Medical Education). We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with AMA PRA Category 1 Credit™ for re-licensure.
The National Commission on Certification of Physician Assistants (NCCPA) states that AMA PRA Category 1 Credits™ are acceptable for continuing medical education requirements for recertification. We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with AMA PRA Category 1 Credit™ for re-licensure.
The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.
This course is intended to provide up-to-date, state-of-the-art continuing medical education for primary care physicians and clinicians who are on the front lines of identifying and managing a wide spectrum of diabetes and endocrine disorders. In order to be successful, it is critically important that you know when and how to identify important endocrine disorders in adults, when to screen for them and how best to manage your patients with obesity and type 2 diabetes.
It minimizes unnecessary investigations and misinterpretation of data. If you provide care to patients with endocrine disorders, diabetes or obesity, this course will be invaluable. You will leave with comprehensive strategies, the latest clinical updates and best practices to optimize patient care while enjoying historic Boston in the spring.
• Screening and treating of osteoporosis – understanding the new medications
• Intensifying treatment of people with type 2 diabetes
• Initiation and intensification for insulin in people with type 2 diabetes
• Personalizing nutrition plans and exercise prescriptions for people with diabetes
• Using medications to treat obesity
• Managing people with thyroid dysfunction – hypo- and hyperthyroidism
• How to best evaluate thyroid nodules
• Improving cardiovascular risk
• Menopausal symptom management
• When to suspect and how to initially screen for pituitary and adrenal dysfunction
• Endless activities including theater, museums, fine dining, shopping, historic landmarks and more located just outside the Revere Hotel Boston Common
Upon completion of this activity, participants will be able to:
• Assess the potential for an underlying endocrine etiology for patients presenting with subtle and non-specific symptoms
• Select appropriate laboratory and imaging assessments to initiate the evaluation and management planning of patients suspected of having endocrine disease.
• Evaluate and, when appropriate, refer patients to a consultant endocrinologist for further diagnostic evaluation, advanced therapeutic intervention and co-management when appropriate
• Manage common endocrine conditions such as Type 2 diabetes, Osteoporosis, Vitamin D Deficiency, and primary hypothyroidism.
• Recognize the importance of non-alcoholic fatty liver disease
|Contact No. :||(617) 384-8600
|Registration Type||Last Date||Price|
|Physician (MD/DO) - Early Fee||03 Jan,2020||USD 595.00|
|Allied Health Professional / Other - Early Fee||03 Jan,2020||USD 595.00|